Surgery or ART? A dearth of strong evidence reported at Campus meeting to favour specific infertility treatments in cases of endometriosis.
Despite a long history of controversy, a new expert review of progesterone supplementation in women at risk of recurrent miscarriage advises that many women 'may benefit'.
Once again, adjuvant treatments to improve the chance of live birth are under the spotlight. New reviews of more than 20 clinical, endometrial and laboratory add-ons find no persuasive evidence for their application in everyday practice.
An official China news agency reports that the biophysicist behind the birth of gene edited twins in 2018 has been found guilty of violating research regulations.
Despite its high prevalence and devastating personal consequences, endometriosis remains far from clearly understood, and especially its effects on implantation and pregnancy.
New systematic review concludes that IUI with gonadotrophin stimulation for unexplained infertility cannot be supported because of multiple gestation risk.
An ESHRE expert meeting in November reviewed what we know so far about open access publishing for medical journals. The meeting in particular explored where we now are with Plan S and how its implementation might affect the Human Reproduction journals.
2020 ANNUAL MEETING
Anja Pinborg, a local organiser of this year's annual meeting in Copenhagen, on the impact of state-funded IVF and the potential of Danish national registries to assess the long-term safety of ART.
It is now 13 years since the Belgian gynecologist Willem Ombelet organised a meeting with ESHRE's support in the Tanzanian town of Arusha. There, 37 experts galvanised their ideas for bringing safe, affordable and effective IVF to countries thus far beyond the reach of treatment. In this podcast Ombelet reviews progress since those visionary days.
ACCESS TO TREATMENT
A Campus meeting in December concluded that global access to effective fertility can be achieved, but only with the combined commitments of fertility education, affordable treatment, and the support of governments.